:: infobox .infobox-celltype
Allen Atlas ID: CS202210140_3700
Lineage: Neuron > GABAergic > Interneuron > SST+ Interneuron
Markers: SST (Somatostatin), CALB1, GAD1, GAD2, NPY
Brain Regions: Cortex (layers 1-6), Hippocampus (CA1/CA3 strata radiatum/lacunosum-moleculare)
Disease Vulnerability: Alzheimer's Disease, Schizophrenia, Epilepsy, Huntington's Disease
::
Somatostatin Positive (Sst+) Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Somatostatin-positive (SST+) interneurons represent a major class of cortical and hippocampal inhibitory neurons, comprising approximately 20-30% of all cortical interneurons. These neurons are characterized by their expression of the neuropeptide somatostatin (SST), which acts as both a neurotransmitter and neuromodulator. SST+ interneurons primarily target the dendritic domains of pyramidal neurons, making them ideally positioned to regulate synaptic integration, dendritic computation, and plasticity. Unlike PV+ interneurons that control perisomatic inhibition, SST+ cells modulate the efficacy of excitatory inputs arriving at pyramidal neuron dendrites. This positions SST+ neurons as critical regulators of information flow into neurons and as key players in processes like dendritic integration, learning, and memory.
Dysfunction of SST+ interneurons is implicated in Alzheimer's disease, where they contribute to hippocampal hyperactivity and memory deficits, as well as in schizophrenia, epilepsy, and Huntington's disease.
Several distinct subtypes:
Martinotti Cells
Non-Martinotti SST+ Cells
In the hippocampus:
The defining neuropeptide:
SST+ neurons often co-express:
SST+ neurons show distinctive properties:
SST+ neurons regulate:
Martinotti cells mediate disinhibition:
SST+ interneuron dysfunction in AD:
Research shows that SST+ interneuron loss precedes amyloid-beta plaque formation in APP/PS1 mice, suggesting a role in early disease pathogenesis. The reduction in SST+ neurons contributes to circuit hyperexcitability that characterizes early Alzheimer's disease.
SST+ cell abnormalities in schizophrenia:
Post-mortem studies have consistently shown reduced SST mRNA and protein levels in the prefrontal cortex of schizophrenic patients, linking to deficits in GABAergic signaling.
Role in seizure networks:
SST+ interneurons are particularly vulnerable to seizure-induced death, contributing to the circuit hyperexcitability that characterizes chronic epilepsy.
SST+ neuron involvement in HD:
Somatostatin Positive (Sst+) Interneurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Somatostatin Positive (Sst+) Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Rudy B, Fishell G, Lee S, Hjerling-Leffler J. "Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons." Developmental Neurobiology (2011). PMID:21350059
Urban-Ciecko J, Barth AL. "Somatostatin-expressing neurons in cortical networks." Nature Reviews Neuroscience (2016). PMID:27256555
McBain CJ, Kauer JA. "Presynaptic plasticity: targeted synaptic inhibition." Current Opinion in Neurobiology (2009). PMID:19349158
Freund TF, Katona I. "Perisomatic inhibition." Neuron (2007). PMID:17964251
Jiang X, Shen S, Cadwell CR, et al. "Principles of connectivity among morphologically defined cell types in adult neocortex." Science (2015). PMID:26571462
Xu H, Jeong HY, Tremblay R, Rudy B. "Neocortical somatostatin-expressing GABAergic interneurons disinhibit the thalamocortical circuit." Neuron (2014). PMID:24462003
Verret L, Mann EO, Hang GB, et al. "Inhibitory neuron loss in an Alzheimer's disease model." Neuron (2012). PMID:22481254
Lawrence JJ, Saraga F, Churchill JF, et al. "Somatostatin-containing interneurons control the timing of theta and gamma oscillations in the hippocampus." Journal of Neuroscience (2010). PMID:20844120
Turrigiano G. "Too many cooks? Intrinsic and synaptic homeostatic plasticity in development and disease." Neuron (2020). PMID:32822615
Lim D, Cho J, Ershler F, et al. "Somatostatin peptide signaling through somatostatin receptors in Alzheimer's disease." Journal of Alzheimer's Disease (2023). PMID:37638421